December is here; the end of 2023 fast approaches. For those operating in the life sciences sector, it’s all too clear that the time has come for 2024 industry predictions.
Genomic technology company Biofidelity has announced the launch of ASPYRE-Lung reagents (RUO) for research use, marking its second product launch this year, with the aim of providing simple
Malaria, a disease caused by the plasmodium parasite and transmitted through the bite of infected mosquitoes, has been a long-standing global health challenge.
